Drugs / FFP
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT07032792 Comparator | Nov 2025 → Nov 2028 expected | heart disorder, hemorrhagic disease | Northwell Health | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FFP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07032792 ↗ |
| Route | Intravenous | “receive up to 2 units of FFP intravenously” NCT07032792 ↗ |